Insiders · GRCE

Amresh Kumar

VP Program Management at Grace Therapeutics, Inc. (GRCE) since May 2023

Amresh Kumar has filed 6 insider reports with the SEC since May 2023, as VP Program Management at Grace Therapeutics, Inc. (GRCE). The latest filing, on September 1, 2026, reports grant or award at Grace Therapeutics, Inc. (GRCE).

Filings

6

Companies

1

Bought on market

None

Sold on market

None

Companies where Amresh Kumar is an insider

Company	Role	Shares held	Bought	Sold	Avg buy	Price now	Last filing
GRCE Grace Therapeutics, Inc.	VP Program Managementsince May 2023	66,712				$1.81	Sep 1, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

• Aug 28, 2026
  GRCESEC Form 4 filed by VP Program Management Kumar Amresh

  Form 4Grant or award
• Apr 14, 2025
  GRCESEC Form 4 filed by VP Program Management Kumar Amresh

  Form 4Grant or award
• May 6, 2024
  GRCESEC Form 4 filed by Kumar Amresh (Amendment)

  Form 4Grant or award
• May 6, 2024
  GRCESEC Form 4 filed by Kumar Amresh

  Form 4Grant or award
• Jul 14, 2023
  GRCESEC Form 4 filed by Kumar Amresh

  Form 4Grant or award
• May 8, 2023
  GRCESEC Form 3: New insider Kumar Amresh claimed ownership of 66,712 units of Class A Common Shares

  Form 3New insider

Compare Amresh Kumar with

• Amresh Kumar vs Edward Neugeboren1 shared
• Amresh Kumar vs A Brian Davis1 shared
• Amresh Kumar vs Vimal Kavuru1 shared
• Amresh Kumar vs George Kottayil1 shared
• Amresh Kumar vs Prashant Kohli1 shared
• Amresh Kumar vs R. Loch Macdonald1 shared

Other insiders at the same companies

• Opaleye Management Inc.GRCE
• Edward NeugeborenGRCE
• A Brian DavisGRCE
• Vimal KavuruGRCE
• George KottayilGRCE
• Prashant KohliGRCE
• Robert J DelAversanoGRCE
• R. Loch MacdonaldGRCE
• Carrie D'AndreaGRCE

Questions about Amresh Kumar

What is Amresh Kumar's role at Grace Therapeutics, Inc.?

Amresh Kumar reports to the SEC as VP Program Management at Grace Therapeutics, Inc. (GRCE), according to the latest filing on September 1, 2026.

How many shares does Amresh Kumar own?

After the latest filing that states it, Amresh Kumar directly owned 66,712 shares of Grace Therapeutics, Inc. (GRCE). Shares held through trusts, funds or family members are reported separately and are not counted here.

Has Amresh Kumar bought or sold stock recently?

No open-market purchases or sales by Amresh Kumar are on file. The filings report grant or award.

How do I get alerts when Amresh Kumar files?

Follow Amresh Kumar on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Amresh Kumar filed 1 time in the last 90 days.

From SEC Forms 3, 4, 5 and 144 filed by Amresh Kumar (SEC CIK 0001978220). Totals count each trade once, skipping amendments whose original is on file, from May 18, 2023 on. View on SEC EDGAR